🚀 VC round data is live in beta, check it out!

Evrofarma Valuation Multiples

Discover revenue and EBITDA valuation multiples for Evrofarma and similar public comparables like Skane-Mollan, Helio, Premium Snacks Nordic, Lifevantage and more.

Evrofarma Overview

About Evrofarma

Evrofarma SA through its subsidiary Campus SA produces milk and dairy products such as yogurt and cheese. The company also trades animal feed and animals such as cows, goats and sheep. Its products include Yellow Cheese, Anthotiro, Telemes, Cow's yogurt, Goat's cheese and Feta DPO.


Founded

1991

HQ

Greece

Employees

148

Financials (FY)

Revenue:
Net Income:

EV

$58M

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Evrofarma Stock Performance

Evrofarma has current market cap of $58M, and enterprise value of $58M.

Market Cap Evolution


Evrofarma's stock price is $4.26.

See Evrofarma trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$58M$58M(0.2%)XXXXXXXXX

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Evrofarma Valuation Multiples

Evrofarma Financial Valuation Multiples

As of March 7, 2026, Evrofarma has market cap of $58M and EV of $58M.

Equity research analysts estimate Evrofarma's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$58MXXX$58MXXXXXXXXX
EV (current)$58MXXX$58MXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Evrofarma Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Valuation Multiples Across 230+ Verticals

Evrofarma Public Comps

See public comps and valuation multiples for other Food & Beverages comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
Skane-MollanXXXXXXXXXXXXXXXXXX
HelioXXXXXXXXXXXXXXXXXX
Premium Snacks NordicXXXXXXXXXXXXXXXXXX
LifevantageXXXXXXXXXXXXXXXXXX
New Zealand King SalmonXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Evrofarma M&A Activity

Evrofarma acquired XXX companies to date.

Last acquisition by Evrofarma was on XXXXXXXX, XXXXX. Evrofarma acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Evrofarma

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Evrofarma Investment Activity

Evrofarma invested in XXX companies to date.

Evrofarma made its latest investment on XXXXXXXX, XXXXX. Evrofarma invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Evrofarma

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Evrofarma

When was Evrofarma founded?Evrofarma was founded in 1991.
Where is Evrofarma headquartered?Evrofarma is headquartered in Greece.
How many employees does Evrofarma have?As of today, Evrofarma has over 148 employees.
Is Evrofarma publicly listed?Yes, Evrofarma is a public company listed on Athens Stock Exchange.
What is the stock symbol of Evrofarma?Evrofarma trades under EVROF ticker.
When did Evrofarma go public?Evrofarma went public in 2000.
Who are competitors of Evrofarma?Evrofarma main competitors are Skane-Mollan, Helio, Premium Snacks Nordic, Lifevantage.
What is the current market cap of Evrofarma?Evrofarma's current market cap is $58M.
Is Evrofarma profitable?No, Evrofarma is not profitable.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial